Comparative study of high-dose Xuezhikang and low-dose Xuezhikang plus ezetimibe on pro- and anti-inflammatory markers

Clinical Lipidology , February 2013, Vol. 8, No. 1, Pages 151-157.

Source: Future Medicine: Clinical Lipidology - February 5, 2013 Category: Lipidology Tags: article Source Type: research